Skip to main content
TipRanks
Go Ultimate75% OFF

Katina Dorton Insider Profile

4 Followers

Katina Dorton, Director at Fulcrum Therapeutics, holds ― shares in Fulcrum Therapeutics (Ticker: FULC), holds 0.00 shares in US Ecology (Ticker: ECOL), holds 10.00K shares in Tectonic Therapeutic (Ticker: TECX).

Katina Dorton's Trading History

ECOL
US Ecology
May 03, 2022―Uninformative Sell648.00K$0.00
TECX
Tectonic Therapeutic
Oct 10, 2018Chief Financial OfficerUninformative Buy9.10K$209.80K
TCRX
TScan Therapeutics
―Director――
PRLD
Prelude Therapeutics
―Director――
PAND
Pandion Therapeutics
――――
FULC
Fulcrum Therapeutics
―Director――

You May Also Like

Katina Dorton insider profile FAQ

What is the percentage of profitable transactions made by Katina Dorton?
The percentage of profitable transactions made by Katina Dorton is 17%.
What is the average return per transaction made by Katina Dorton?
The average return per transaction made by Katina Dorton is -8.60%.
What stocks does Katina Dorton hold?
Katina Dorton holds: FULC, ECOL, TECX, PAND, PRLD, TCRX stocks.
What was Katina Dorton's most profitable transaction?
Katina Dorton’s most profitable transaction was an Informative Buy of ECOL stock on May 29, 2020. The return on the trade was 17.70%.
What is Katina Dorton's role in Fulcrum Therapeutics?
Katina Dorton's role in Fulcrum Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.